Contact Us
Let's Map Your
Pathway to Access.
Whether you're preparing a first submission, navigating a CE-MDR transition, or designing a global market-access strategy — tell us where you are and we'll connect you with the right senior lead. Not a sales rep. A real expert conversation, responded to within one business day.
Get in Touch
Three Ways to Start the Conversation.
Reach us however suits you — every enquiry is routed to a senior expert in the relevant field, not a general inbox.
Email Us
For general enquiries, capability requests and partnership discussions. Responded to within one business day.
Book a Consultation
A focused, no-obligation call with a regulatory, clinical or market-access lead — confidential under NDA if required.
Visit an Office
Three regional hubs across APAC, EMEA and the Americas — one shared ISO 9001:2015 quality system in each.
Get Started
Build Your Evidence-to-Reimbursement™ Pathway
Tell us about your programme, stage and target markets. We'll match the right integrated team — clinical, regulatory, safety or market access — and get back to you with a real expert, not a generic proposal.
Responded to within 1 business dayA real expert conversation, not a generic proposal.
Senior expert, not a sales callSpeak directly with a regulatory or clinical lead.
Confidential under NDA if requiredYour programme details stay protected.
Book a Strategy Consultation
Tell us about your programme and we'll match the right team.
Global Offices
Three Cities. One Quality System.
Three regional hubs covering Asia-Pacific, EMEA and the Americas — with the same SOPs, same training matrix, same accountability chain in each.
Hyderabad
India · APAC Hub
Global headquarters. CDSCO submissions, Indian authorised agent services, Asia-Pacific clinical operations and the largest regulatory + PV delivery team.
London
United Kingdom · EMEA Hub
EMA and MHRA liaison. EU QPPV cover. NICE and EMA scientific advice. EU MDR + IVDR notified body relationships. EMEA market access.
Boston
United States · Americas Hub
FDA liaison and submission strategy. Boston biotech corridor presence. US payer engagement, AMCP dossiers and Americas clinical operations.